Mandate

Vinge has advised XVIVO in conjunction with its directed share issue of SEK 440 million.

September 14, 2023 M&A

Vinge has advised XVIVO Perfusion AB in connection with its directed share issue at a subscription price of SEK 275 per share which corresponded to the closing price of XVIVO’s shares on Nasdaq Stockholm on the day of the issue.

XVIVO received SEK 440 million before issue costs. The subscription price was determined through an accelerated bookbuilding procedure arranged by Carnegie and DNB Markets. Investors in the directed share issue were both existing and new shareholders such as Bure Equity AB, the Fourth Swedish National Pension Fund, Swedbank Robur Fonder, Eccenovo, Handelsbanken Fonder, Tredje AP-fonden and a Tier-1 global international investor.

Vinge's team primarily consisted of Anders Strid and project manager Edin Agic.

 

Related

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024

Vinge has advised Triton in connection with sale of shares in Ambea AB (publ)

In total, 7.6 million shares were placed at a price of SEK 64 per share, corresponding to a total value of approximately SEK 489 million.
May 27, 2024

Vinge advises Axcel in connection with the sale of Loopia Group to team.blue

Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading digital enabler for entrepreneurs and SMBs and backed by Hg, a leading investor in European and transatlantic software and services businesses.
May 23, 2024